- PLUS was largest, best-selling infused gummies brand in California in 2019
- Launch of new Plus Products CBDRelief brand extends portfolio into wellness and relief market
- Company plans another successful launch in strategic pursuit to become the world’s strongest cannabis brand
Kleenex, Xerox, Coca-Cola: Through hyper-focused brand cultivation, these companies’ products have become symbols of their respective categories. As it strives to become the preferred edibles brand in the world, Plus Products Inc. (CSE: PLUS) (OTCQX: PLPRF) is channeling this strategy, choosing a core product on which to build a strong brand name before branching out. As a result, Plus has become California’s preferred cannabis gummies brand of choice: After introducing its edible gummy line to the market in 2016, the company’s offerings reached top two spots in the highly competitive California market in less than two years.
Plus Products is working to offer high-quality edibles formulated to support a healthy and active lifestyle while still being accessible and affordable. The core PLUS brand was the largest cannabis-infused gummies brand with the best-selling cannabis product in California in 2019.
The company’s success is due in no small part to its product quality. Plus Products delivers a consistent, dosable and delicious cannabis experience. After proving its core brand in the highly competitive adult-market of California, the company is expanding its product line into the wellness and relief market segment. In February, PLUS announced the launch of a new Plus CBDRelief brand (http://cnw.fm/UfI7q).
“We have seen compelling success with our core brand and are excited to take the next step towards becoming a true portfolio of brands with the launch of PLUS CBDRelief,” PLUS co-founder and CEO Jake Heimark stated in a news release. “Last year we partnered with market structure research firm, HJR Associates, and found that when consumers used cannabis, over one-third of the time it was to address pain, stress or anxiety.”
Thus far, the wellness and relief market has been underserved, and PLUS sees an opportunity to provide an innovative product line for consumers who are looking for relief. The new line consists of two products: PLUS CBDRelief 9:1 Tropical Mango and PLUS CBDRelief 18:1 Tart Cherry. This new product line delivers the highest CBD content per package for gummies in the California marketplace while still maintaining the brand’s identity of precision dosing and high-quality products.
“Research suggests that people are looking to cannabis as a holistic tool for relief. It’s exciting to leverage rigorous science to formulate great products that enable people to help themselves,” stated PLUS Chief Scientific Officer Dr. Ari Mackler, in reference to proprietary research conducted by a third-party firm. “Research on cannabis is progressing quickly, and we are driving our portfolio of products with innovative science and technologies that will support our customers’ health and wellness goals.”
In Q3 2019, revenues were at $3.5 million – a 38% year-over year increase. That same quarter, PLUS launched a nationwide 100% hemp CBD edible line available online at PlusProducts.com. In Q4, PLUS continued with another successful launch, this time into Nevada’s adult-use cannabis market.
By building a brand and maintaining the top position for gummies for six quarters in the most competitive cannabis market in the world, PLUS has developed a strategy that works. The company’s launch of the CBDRelief brand is the next step in a strategic plan toward growth in making cannabis safe and approachable with high-quality products that deliver consistent consumer experiences.
Plus Products is now moving forward with its eyes on becoming the world’s strongest cannabis brand portfolio.
For more information, visit the company’s website at www.PlusProducts.com
NOTE TO INVESTORS: The latest news and updates relating to PLPRF are available in the company’s newsroom at http://cnw.fm/PLPRF
About CBDWire
CBDWire (CBDW) is a specialized information provider focused on (1) reporting CBD-related news and updates, (2) releasing CBDNewsBreaks crafted to keep investors abreast of the latest and greatest in the CBD market, (3) refining and enhancing corporate press releases, (4) delivering end-to-end distribution and social media services to client-partners and (5) constructing effective corporate communication solutions based on the unique requirements of CBD companies. CBDW is exclusively positioned in the burgeoning CBD sector with a proven team of journalists and researchers working to deliver high quality content to an expansive target audience of investors, consumers and industry news outlets. Our dissemination network of over 5,000 downstream distribution points allows us to deliver unparalleled reach, visibility and recognition to companies operating in both cannabidiol and the wider cannabis space. CBDWire (CBDW) is where CBD news, content and information converge.
To receive instant SMS alerts, text CBDWire to 21000 (U.S. Mobile Phones Only)
For more information please visit https://www.cbdwire.com
Please see full terms of use and disclaimers on the CBDWire website applicable to all content provided by CBDW, wherever published or re-published: https://CBDWire.com/Disclaimer
Do you have a questions or are you interested in working with CNW? Ask Our Editor
CBDWire (CBDW)
Denver, Colorado
www.cbdwire.com
303.498.7722 Office
Editor@CBDWire.com
CBDWire is part of the InvestorBrandNetwork.
